Situation

A symptomatic female patient of 71 years, 161cm, 55kg, was recorded with CHART in primary care because cardiovascular disease is suspected by symptoms.

 

CHART Report Interpretation

 

Risk Assessment

• 71-year-old, skinny BMI = 21kg/m2,

• No other information

 

HART-Findings and HF prediction

Abnormal HART summary:

• Abnormal LV hypertrophy

• Mild AV and MV insufficiency

 

HF prediction:

• Estimated LVEF = 63%

• HF unlikely

 
Report

ECG

ECG is normal. ECG-based LVH score = 0.

ECG did not indicate mild LVH or MV insufficiency (regurgitation).

 

ECG

PCG

PCG is rather normal, there are only a few borderline sound amplitudes. The heart signal in PCG1 is weak, this is interpreted as passable quality PCG signal. Maybe no murmurs. the opening snap is probably connected to MV insufficiency.

 

PCG
 

MCG

MCG systolic time intervals show prolonged EMAT (EMAT=93ms), which indicates any abnormality in systolic function.

  

MCG
 

Decision Support

CHART decision support outcome: Send this patient to cardiology for further diagnosis and treatment with routine priority.

Decision - chart report

 

Echocardiographic Results

LV Hypertrophy (LVMI=177g/m2) with preserved systolic function (EF=62%)

MV insufficiency is moderate but needs only pharmacological treatment.

The Aorta wall mildly thickened.

The patient has no heart failure but is classified as borderline HFpEF.

 

Conclusion

The patient has LVH, which is correctly predicted by HART-findings, but missed by ECG. This becomes the primary decisive finding inpatient referral to cardiology.

The prediction of mild mitral regurgitation was correct, the mild aortic regurgitation is false positive, however, the aorta wall is thickened.

Correct LVEF estimation by CHART.

 

 

Subscribe to get our latest news

* indicates required

Please select all the ways you would like to hear from Cardio Phoenix:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Comments (0)

*your email will not be published

No comments.